COMPUTED DESCRIPTORS
| Molecular Weight | 4858 g/mol |
|---|---|
| XLogP3 | -30.8 |
| Hydrogen Bond Donor Count | 70 |
| Hydrogen Bond Acceptor Count | 77 |
| Rotatable Bond Count | 170 |
| Exact Mass | 4857.5510314 g/mol |
| Monoisotopic Mass | 4855.5443218 g/mol |
| Topological Polar Surface Area | 2090 Ų |
| Heavy Atom Count | 342 |
| Formal Charge | 0 |
| Complexity | 11800 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 42 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Lixisenatide is a forty-four membered polypeptide consisting of L-His, Gly, L-Glu, Gly, L-Thr, L-Phe, L-Thr, L-Ser, L-Asp, L-Leu, L-Ser, L-Lys, L-Gln, L-Met, L-Glu, L-Glu, L-Glu, L-Ala, L-Val, L-Arg, L-Leu, L-Phe, L-Ile, L-Glu, L-Trp, L-Leu, L-Lys, L-Asn, Gly, Gly, LPro, L-Ser, L-Ser, Gly, L-Ala, L-Pro, L-Pro, L-Ser, L-Lys, L-Lys, L-Lys, L-Lys, L-Lys, and L-Lys-NH2 residues joined in sequence. Used as an adjunct to diet and exercise for the treatment of adults with type II diabetes. It has a role as a glucagon-like peptide-1 receptor agonist, a hypoglycemic agent and a neuroprotective agent. It is a polypeptide and a peptidyl amide.